Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

C4 Therapeutics (CCCC) Asset Utilization Ratio (2020 - 2025)

Historic Asset Utilization Ratio for C4 Therapeutics (CCCC) over the last 6 years, with Q3 2025 value amounting to 0.11.

  • C4 Therapeutics' Asset Utilization Ratio rose 2047.59% to 0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.11, marking a year-over-year increase of 2047.59%. This contributed to the annual value of 0.1 for FY2024, which is 9062.19% up from last year.
  • Per C4 Therapeutics' latest filing, its Asset Utilization Ratio stood at 0.11 for Q3 2025, which was up 2047.59% from 0.11 recorded in Q2 2025.
  • C4 Therapeutics' 5-year Asset Utilization Ratio high stood at 0.12 for Q1 2025, and its period low was 0.04 during Q2 2023.
  • For the 5-year period, C4 Therapeutics' Asset Utilization Ratio averaged around 0.08, with its median value being 0.09 (2021).
  • As far as peak fluctuations go, C4 Therapeutics' Asset Utilization Ratio crashed by 5814.17% in 2023, and later skyrocketed by 12992.2% in 2025.
  • C4 Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.09 in 2021, then fell by 22.77% to 0.07 in 2022, then decreased by 16.05% to 0.06 in 2023, then skyrocketed by 67.61% to 0.1 in 2024, then increased by 9.25% to 0.11 in 2025.
  • Its last three reported values are 0.11 in Q3 2025, 0.11 for Q2 2025, and 0.12 during Q1 2025.